SCHEMBL756048

SCHEMBL756048

CC(C)CCCCCCCCCCC=O

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.52
FAAH O00519 2/20 0.46
TRPV1 Q8NER1 2/20 0.46
HIF1A Q16665 4/20 0.45
LMNA P02545 1/20 0.43
EPAS1 Q99814 3/20 0.41
ADH1B P00325 2/20 0.35
ADH1C P00326 2/20 0.35
ADH1A P07327 2/20 0.35
ADH4 P08319 1/20 0.35
ADH7 P40394 1/20 0.35
ALDH1A1 P00352 2/20 0.35
KDM4C Q9H3R0 2/20 0.33
KDM4A O75164 1/20 0.33
PHF8 Q9UPP1 1/20 0.33
KDM2A Q9Y2K7 1/20 0.33
KDM1A O60341 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4978224 1.00 TSHR (0.52) TSHRFAAHTRPV1HIF1ALMNA
SCHEMBL294142 1.00 TSHR (0.52) TSHRFAAHTRPV1HIF1ALMNA
SCHEMBL293702 1.00 TSHR (0.52) TSHRFAAHTRPV1HIF1ALMNA
SCHEMBL536858 1.00 TSHR (0.52) TSHRFAAHTRPV1HIF1ALMNA
SCHEMBL443450 1.00 TSHR (0.52) TSHRFAAHTRPV1HIF1ALMNA
SCHEMBL2523320 1.00 TSHR (0.52) TSHRFAAHTRPV1HIF1ALMNA
SCHEMBL5654128 1.00 TSHR (0.52) TSHRFAAHTRPV1HIF1ALMNA
SCHEMBL15327039 1.00 TSHR (0.52) TSHRFAAHTRPV1HIF1ALMNA
SCHEMBL21619221 1.00 TSHR (0.52) TSHRFAAHTRPV1HIF1ALMNA
SCHEMBL9254348 1.00 TSHR (0.52) TSHRFAAHTRPV1HIF1ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 668 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12568998-B2 Flavouring composition with balanced taste profile SYMRISE AG (DE) 2026-03-10 US claimed
US-20250352444-A1 Antimicrobial mixtures SYMRISE AG (DE) 2025-11-20 US claimed
US-20250325463-A1 COMPOSITIONS (III) SYMRISE AG (DE) 2025-10-23 US claimed
US-20250280857-A1 DEGRADATION-RESISTANT ALDEHYDE-CONTAINING COMPOSITIONS ZOOMESSENCE INC (US) 2025-09-11 US claimed
EP-4444108-B1 ALDEHYDE MIXTURES FOR FLAVOUR IMPROVEMENT SYMRISE AG (DE) 2025-09-10 EP claimed
EP-4565194-A1 ODOR AND COLORANT STABILIZED COMPOSITIONS Symrise AG (DE) 2025-06-11 EP claimed
US-20250163006-A1 New Coolants, and Preparations Containing Same SYMRISE AG (DE) 2025-05-22 US claimed
CN-119924491-A Flavoring composition with balanced taste characteristics 西姆莱斯有限公司 2025-05-06 CN claimed
CN-119744164-A Odor and colorant stable compositions 西姆莱斯股份公司 2025-04-01 CN claimed
EP-4525822-A1 ANTIMICROBIAL MIXTURES Symrise AG (DE) 2025-03-26 EP claimed
US-20120107477-A1 THERMALLY STABLE HIGH IMPACT FLAVORING PARTICLES SYMRISE AG (DE) 2012-05-03 US claimed
EP-2043451-B1 CYCLODEXTRIN BLENDS WITH CRYSTAL GROWTH INHIBITORS SYMRISE AG (DE) 2012-03-21 EP claimed
CN-102326766-A Preparation method of beef oily essence TIANJIN CHUNFA FOOD ADDITIVES 2012-01-25 CN claimed
US-20090305943-A1 CYCLODEXTRIN BLENDS WITH CRYSTAL GROWTH INHIBITORS SYMRISE GMBH & CO. KG (DE) 2009-12-10 US claimed
EP-2043451-A1 CYCLODEXTRIN BLENDS WITH CRYSTAL GROWTH INHIBITORS Symrise GmbH & Co. KG (DE) 2009-04-08 EP claimed
WO-2008009512-A1 CYCLODEXTRIN BLENDS WITH CRYSTAL GROWTH INHIBITORS SYMRISE GMBH & CO. KG (DE) 2008-01-24 WO claimed
US-5629288-A BACTERICIDE HOECHST AKTIENGESELLSCHAFT (DE) 1997-05-13 US claimed
EP-0688789-A1 Lipopeptid-derivatives, process for their preparation and their use HOECHST AKTIENGESELLSCHAFT (DE) 1995-12-27 EP claimed
CN-1111640-A Lipopeptide derivatives, a process for their preparation and their use HOECHST AG (DE) 1995-11-15 CN claimed
US-5352689-A Rhizoxin derivatives and their use as anti-tumor agents SANKYO COMPANY, LIMITED (JP) 1994-10-04 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12568998-B2 Flavouring composition with balanced taste profile TAS2R20, TAS2R50, TAS2R40 TSHR 1519/4885FAAH 2775/4885TRPV1 514/4885
US-20250352444-A1 Antimicrobial mixtures LRBA, MGLL, TAS2R50 TSHR 3863/4885FAAH 1731/4885TRPV1 147/4885
US-20250163006-A1 New Coolants, and Preparations Containing Same TTR, TAS2R5, TAS2R50 TSHR 2090/4885FAAH 1039/4885TRPV1 95/4885
US-20250325463-A1 COMPOSITIONS (III) NISCH, TAS1R3, TAS2R3 TSHR 2980/4885FAAH 717/4885TRPV1 20/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.